Explore the full record of transactions filed by 배기룡, Chief Executive Officer. Insider active across 2 companies, notably 광동제약. Cumulatively, 10 filings have been recorded. The latest transaction was disclosed on 27 February 2026 — Purchase. Regulator: DART (FSS). All data is free.
Bae Gi-ryong is an Executive Director at Kwangdong Pharmaceutical, a pharmaceutical company. With significant experience in the sector, he is responsible for the strategy and direction of the organization. Bae Gi-ryong plays a key role in optimizing operations and innovation, thereby contributing to the sustainable growth of the company. His commitment to operational excellence is essential for maintaining Kwangdong Pharmaceutical's position in the market.